University Hospitals Cleveland Medical Center

New paper describes use of geographic monitoring for early COVID cluster detection

GeoMEDD enhances traditional mapping to find location of group outbreaks

Newswise — CLEVELAND – In a new paper, researchers describe their development of a near-real time spatial assessment of COVID-19 cases to help guide local medical responses to clusters of outbreaks of the virus at the local level. 

The paper, entitled “Geographic monitoring for early disease detection (GeoMEDD),” appeared in the Dec. 10 issue of Nature Scientific Reports and comes from researchers at Case Western Reserve University (CWRU) School of Medicine, University Hospitals (UH) Cleveland Medical Center, and Texas A & M University.

While developing a tracking system during the beginning stages of the COVID-19 pandemic, the authors realized that there was a need to refocus more traditional spatial mapping towards a more granular cluster detection methodology that provides syndromic surveillance, or early indicators of emergent disease by leveraging a health system’s access to data streams from various sources which account for location and timing of cases. 

“Without such integration, there are missed opportunities for hospitals, health departments, and community leaders to mobilize early intervention activities and save lives. This information provides insights to targeted community testing opportunities, post-acute care intervention, and targeted community education in areas with community spread,” said lead author Andrew Curtis, PhD, Co-Director of the GIS Health & Hazards Lab and Professor in the Department of Population and Quantitative Health Sciences at the CWRU School of Medicine.

“From a hospital and health system perspective, such disease propagation can rapidly tax capacity and resources. From a humanitarian dimension, being able to communicate with local communities, municipality or even building managers requires both time and space insights,” said Curtis.

The authors propose, for example, that positive COVID-19 test results could be analyzed in real time as they flow into a health system, which when combined with severity of the associated symptoms, details such as age and previous medical histories of the patient, and the background neighborhood “risk” could all be added to provide a contextualized understanding of not only where disease occurs but why, and where it is likely to spread next.

“Early detection is critical to interception and potential spread of disease, and is helpful at identifying areas of vulnerability so that efforts can be adequately prioritized,” said Jayakrishnan Ajayakumar, PhD, Lab Manager of the GIS Health & Hazards Lab in the Department of Population and Quantitative Health Sciences at the CWRU School of Medicine, who developed the necessary software. “The tracking system also helps prepare medical and first response teams for potential surge planning.”

GeoMEDD does not replace traditional forms of disease cluster detection, rather it enhances investigation in near real-time and in the context of health system operations to a dynamic situation.

“Syndromic surveillance interest lies in the first case in a post-acute care home, or the timing pattern of emerging positives in an apartment complex, or along a rural street, or how houses on city streets ‘emerge’ suggesting a local transmission mechanism,” said  Maulik Purohit, MD, MPH, Associate Chief Medical Information Officer at UH. “With this information, teams can mobilize to minimize the spread.  This methodology will be relevant for many infectious diseases and operational responses, not just COVID.”

By identifying these emergent patterns in the continuous data streams available to health systems, rational and evidence-based strategies could potentially be used  to reduce further transmission.

“COVID spreads very efficiently in congregate housing and narrowing the time lag between knowledge of an emergent case and implementation of evidence-based interventions could help to save lives,” said Justin Yax, DO, Director of Population Health, Department of Emergency Medicine at UH.

These data have also been helpful to local health departments and community leaders and has gained interest and support from the state. 

While contact tracing remains a vital part of understanding disease spread, the clusters described here reveal geographic patterns and aspects of diffusion in near real time — much sooner than other public health monitoring currently available in the region.

While COVID-19 provided the stimulus for these new method developments, the application extends far beyond this pandemic to potentially other future epidemics, to regular flu seasons, to outbreaks of overdoses, and to surveillance looking for bioterror or radiological symptoms.

“GeoMEDD should be seen as the first step in the development of a suite of clusters nuanced to varying geographies (urban versus rural, even vertical living environments), or specific topics,” said  Jacqueline Curtis, PhD, Co-Director of the GIS Health & Hazards Lab and Associate Professor in the Department of Population and Quantitative Health Sciences at the CWRU School of Medicine.

# # #

About University Hospitals

Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 19 hospitals, more than 50 health centers and outpatient facilities, and 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, located in Cleveland’s University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; University Hospitals Harrington Heart & Vascular Institute, a high-volume national referral center for complex cardiovascular procedures; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development. UH is one of the largest employers in Northeast Ohio with 28,000 physicians and employees. Advancing the Science of Health and the Art of Compassion is UH’s vision for benefitting its patients into the future, and the organization’s unwavering mission is To Heal. To Teach. To Discover. Follow UH on LinkedIn, Facebook @UniversityHospitals and Twitter @UHhospitals. For more information, visit

About Case Western Reserve University

Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 5,100 undergraduate and 6,700 graduate students comprise our student body. Visit to see how Case Western Reserve thinks beyond the possible.



Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Showing results

110 of 4573